Bristol-Myers Squibb Company
NYSE: BMY
$58.87
+$0.64 (+1.1%)
Closing Price on November 22, 2024
BMY Articles
Warren Buffett reduced Berkshire Hathaway's holdings in 13 stocks during the first quarter of this year. Here's how eight of those stocks have performed so far in the second quarter.
Published:
24/7 Wall St. screened the BofA Securities research universe looking for Buy-rated stocks in the so-called defensive growth sectors, such as consumer staples and big pharmaceuticals, and found five...
Published:
Even though the economy is starting to open up, it may be time for investors to move to more defensive positions. These BofA Securities stock picks pay dependable dividends and can soften the blow if...
Published:
These five Goldman Sachs high-conviction stock picks look like outstanding total return ideas now. They are positioned well for the rest of 2021 and beyond, and they make sense for growth and income...
Published:
Friday's top analyst upgrades and downgrades included AvalonBay Communities, Bristol-Myers Squibb, Carrier, Comcast, CyrusOne, DraftKings, Nvidia and Textron.
Published:
Tuesday's top analyst upgrades and downgrades included Beyond Meat, Booking, Bristol-Myers Squibb, Cloudflare, FedEx, JetBlue Airways, Nvidia, PepsiCo, Square and Zscaler.
Published:
These five top picks from the Goldman Sachs America's Conviction List look poised for great total return potential and less potential volatility in a very overbought stock market. They all pay...
Published:
The analysts at BofA Securities have added an IT services giant to the firm's US 1 List of top stock recommendations. Plus, here are three additional ideas that make sense for growth investors now
Published:
BofA Securities says that, given current market conditions, it makes sense for investors to move to safer stocks that pay dividends. These five look like great places to park some portfolio money now...
Published:
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Published:
With the market bloated and way overbought, what many feel makes sense for 2021 are dividend-paying stocks with solid growth potential that can deliver solid total return. These five top stocks on...
Published:
In a move that investors looking for more defensive ideas should applaud, the analysts at Goldman Sachs have added Bristol-Myers Squibb to the Americas Conviction List. Plus, here are four additional...
Published:
Tuesday's top analyst upgrades and downgrades included Baker Hughes, Bristol Meyers, Chevron, Emerson, Halliburton, HCA, Intuitive Surgical, Medtronic, NXP Semiconductors and Phillips 66.
Published:
These five dividend-paying stocks have solid growth potential and can deliver solid total return. The companies have very strong and defensible business models and products. So their stocks make...
Published:
Rotating from overbought and crowded momentum stocks makes sense now. From a total return standpoint, dividend-paying large-cap pharmaceutical stocks may be one of the best ideas for 2021.
Published: